management Team

Richard Johnson
Founder & CEO

Dr Richard Johnson founded Upperton Pharma Solutions in August 1999, and continues to play a key role in the management and strategic development of the company. With over 30 years of experience in the pharmaceutical, biotechnology and drug delivery fields, Richard previously held senior management positions at Andaris Limited (Vectura) and Delta Biotechnology (now Albumedix). Richard holds an honours degree in Biology from University of York and a Ph.D. from the University of Warwick and has a proven track record in successfully developing innovative pharmaceutical products from early feasibility studies through to commercial products.

Andrew Naylor
R&D Director

Dr Andrew Naylor was appointed R&D Director for Upperton Pharma Solutions in August 2015, having previously held the position of Head of Process Development at Critical Pharmaceuticals. Andrew holds a Masters and PhD degrees in Chemistry from the University of Nottingham. Andrew has extensive experience in the development and analysis of pharmaceutical products. He is a Fellow of the Royal Society of Chemistry, and has sat on several Royal Society of Chemistry special interest group committees in the fields of polymer and materials science.

Paul Kelsall
Director of Clinical Manufacturing

Paul Kelsall joined Upperton Pharma Solutions in August 2018. Paul has over 20 years of experience in the pharmaceutical industry, having previously worked for Boots, Reckitt Benckiser, Nova Laboratories and Aesica. Paul’s experience covers both Sterile and Non-Sterile Manufacturing, Formulation Development, Facilities Management and Business Improvement. Paul’s responsibilities include managing the Upperton Pharma Solutions Facility and all the GMP Operations that are conducted on site. Paul is also responsible for the New Business Introduction of all GMP projects.

Sarah Bayliss
Director of Quality & Compliance

Sarah Bayliss joined Upperton in December 2017 as Director of Quality and Compliance. Her previous roles include Corporate QA Operations Manager, Head of Quality, Technical Manager and General Manager for pharmaceutical and medical device businesses within the manufacturing areas of Europe and the USA. Sarah has over 20 years’ experience of implementing, maintaining and remediating Quality Management Systems, working under MIA, IMP, MS and WD licences. Sarah is responsible for ensuring that Upperton Pharma Solutions are compliant and that our Quality Management Systems are implemented and adhered to in-line with the site relevant licensing activities (GMP) under MHRA & FDA regulations.

Karen Coombes
Commercial Director

Karen Coombes joined Upperton Pharma Solutions as Operations Director in 2008, having previously held positions at Advanced Protein Systems, Andaris Limited (Vectura) and Unilever Research. Karen holds an honours degree in Chemistry from the University of Bath and a master’s degree in Biotechnology from the University Of Nottingham and has a wealth of experience in the pharmaceutical and biotechnology industry. Karen is responsible for scale up projects and for directing all non GMP manufacturing activities in the company’s pilot plant.

Laura Mason
Director of Business Operations

Dr Laura Mason joined Upperton in 2016 as a Project Scientist, quickly progressing to the role of Business Operations Director. Laura has previous experience within solid oral dosage form development having completed her PhD in the School of Pharmacy at the University of Nottingham, and her Pharmacy Pre-Registration Year at Merck Sharp and Dohme and Guy’s & St Thomas’ Hospital. Laura is a UK Registered Pharmacist, the current treasurer of the UKICRS and a member of several pharmaceutical societies. Laura supports the introduction and co-ordination of the company’s R&D projects.

Can we help you?